HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Si M. Pham Robert L. Kormos Rodney J. Landreneau Akihiko Kawai Ivan Gonzalez-Cancel Robert L. Hardesty Brack G. Hattler Bartley P. Griffith Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Pham, S. M. Articles by Griffith, B. P. Search for Related Content PubMed PubMed Citation Articles by Pham, S. M. Articles by Griffith, B. P. Related Collections Related Article

Ann Thorac Surg 1995;60:1623-1626
© 1995 The Society of Thoracic Surgeons

---

Original Articles: Cardiovascular

Solid Tumors After Heart Transplantation: Lethality of Lung Cancer

Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania

Background. Prolonged nonspecific immunosuppression after solid-organ transplantation is associated with an increased risk of certain cancers. This study examined the development of solid-organ tumors after cardiac transplantation.

Methods. Thirty-eight solid tumors were identified in 36 (5.9%) of 608 cardiac transplant recipients who survived more than 30 days. Two patients had two types of skin tumors (basal cell and squamous cell). The tumors included the following types: skin (15), lung (10), breast (1), bladder (2), larynx (2), liver (1), parotid (1), testicle (1), uterus (2), melanoma (2), and Merkel's cell (1). Four immunosuppression regimens based on cyclosporin A or FK 506 were used during this period.

Results. There was no association between the incidence of solid tumors and the use of lympholytic therapy. After the diagnosis of tumor was made, the actuarial 2-year survival rates of recipients with skin, lung, and other solid tumors were 71%, 22%, and 23%, respectively. Eight of 10 patients with lung cancer were in stage IIIA or higher at the time of diagnosis.

Conclusion. Skin and lung tumors are the most frequent solid tumors in heart transplant recipients. Skin tumors (except Merkel's cell carcinoma and melanoma) usually have a benign course, whereas lung and other tumors developing in cardiac transplant recipients carry a poor prognosis. Advanced disease stage at the time of diagnosis is responsible for the dismal outcome of recipients in whom solid tumors develop. Close postoperative tumor surveillance after cardiac transplantation is warranted.

Related Article

Solid Tumors in Cardiac Allograft Recipients

Israel Penn
Ann. Thorac. Surg. 1995 60: 1559-1560. [Extract] [Full Text]

This article has been cited by other articles:

				K. Potaris, B. Radovancevic, C. D. Thomas, I. Gregoric, A. A. Vaporciyan, S. A. Riggs, R. Radovancevic, W. K. Vaughn, and O.H. Frazier Lung Cancer After Heart Transplantation: A 17-Year Experience Ann. Thorac. Surg., March 1, 2005; 79(3): 980 - 983. [Abstract] [Full Text] [PDF]

				P. Bagan, J. Assouad, P. Berna, R. Souilamas, F. Le Pimpec Barthes, and M. Riquet Immediate and Long-Term Survival After Surgery for Lung Cancer in Heart Transplant Recipients Ann. Thorac. Surg., February 1, 2005; 79(2): 438 - 442. [Abstract] [Full Text] [PDF]

				Z. Ahmed, M. B. Marshall, J. C. Kucharczuk, L. R. Kaiser, and J. B. Shrager Lung Cancer in Transplant Recipients: A Single-Institution Experience Arch Surg, August 1, 2004; 139(8): 902 - 906. [Abstract] [Full Text] [PDF]

				J. Kanitakis, L. Alhaj-Ibrahim, S. Euvrard, and A. Claudy Basal Cell Carcinomas Developing in Solid Organ Transplant Recipients: Clinicopathologic Study of 176 Cases Arch Dermatol, September 1, 2003; 139(9): 1133 - 1137. [Abstract] [Full Text] [PDF]

				M. de Perrot, D. A. Wigle, A. F. Pierre, M. S. Tsao, T. K. Waddell, T. R.J. Todd, and S. H. Keshavjee Bronchogenic carcinoma after solid organ transplantation Ann. Thorac. Surg., February 1, 2003; 75(2): 367 - 371. [Abstract] [Full Text] [PDF]

				A. C. Anyanwu, E. R. Townsend, N. R. Banner, M. Burke, A. Khaghani, and M. H. Yacoub Primary lung carcinoma after heart or lung transplantation: Management and outcome J. Thorac. Cardiovasc. Surg., December 1, 2002; 124(6): 1190 - 1197. [Abstract] [Full Text]

				M. Rinaldi, C. Pellegrini, A. M. D'Armini, M. Aiello, M. Negri, E. Arbustini, G. Ippoliti, and M. Vigano Neoplastic disease after heart transplantation: single center experience Eur. J. Cardiothorac. Surg., May 1, 2001; 19(5): 696 - 701. [Abstract] [Full Text] [PDF]

				B. L. Knisely, L. A. Mastey, J. Collins, J. E. Kuhlman, and A. N. Leung Imaging of Cardiac Transplantation Complications RadioGraphics, March 1, 1999; 19(2): 321 - 341. [Abstract] [Full Text] [PDF]

				I. Penn Solid Tumors in Cardiac Allograft Recipients Ann. Thorac. Surg., December 1, 1995; 60(6): 1559 - 1560. [Full Text]